These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9339257)

  • 21. Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation.
    Nabar A; Rodriguez LM; Timmermans C; van Mechelen R; Wellens HJ
    Heart; 2001 Apr; 85(4):424-9. PubMed ID: 11250970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion.
    Turco P; De Simone A; La Rocca V; El Jamal B; Nocerino P; Astarita C; De Matteis C; Messina V; Greco L; Rotunno R; Di Napoli T; Vitale DF; Stabile G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S124-7. PubMed ID: 15683478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment.
    Riva S; Tondo C; Carbucicchio C; Galimberti P; Fassini G; Della Bella P
    Europace; 1999 Oct; 1(4):242-7. PubMed ID: 11220561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation.
    Bandini A; Golia P; Pantoli D; Galvani M; Rusticali F
    Ital Heart J; 2005 Jul; 6(7):584-90. PubMed ID: 16274021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unstable wide complex tachycardia during propafenone therapy.
    Tsai CF; Sia SK; Lin MC; Wu DJ; Ueng KC
    Resuscitation; 2010 Aug; 81(8):1046-7. PubMed ID: 20488610
    [No Abstract]   [Full Text] [Related]  

  • 26. [1/1 nodo-ventricular conduction atrial flutter with amiodarone].
    Perdrix-Andujar L; Paziaud O; Ricard G; Diebold B; Le Heuzey JY
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):259-62. PubMed ID: 15816331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors predisposing to ventricular proarrhythmia during antiarrhythmic drug therapy for atrial fibrillation in patients with structurally normal heart.
    Lin CY; Lin YJ; Lo LW; Chen YY; Chong E; Chang SL; Chung FP; Chao TF; Hu YF; Tuan TC; Liao JN; Chang Y; Chien KL; Chiou CW; Chen SA
    Heart Rhythm; 2015 Jul; 12(7):1490-500. PubMed ID: 25889809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of an electropharmacological transesophageal test in the prevention of paroxysmal atrial fibrillation. Experience with flecainide].
    De Sisti A; Matteucci C; Patrissi T; Accogli S; Di Lorenzo M; Sasdelli M; Ciolli A; Lo Sardo G; Palamara A
    G Ital Cardiol; 1998 Dec; 28(12):1391-9. PubMed ID: 9887393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial flutter with 1:1 atrioventricular conduction precipitated by antazoline (antistine).
    Yahini JH; Nathan D; Charuzi Y; Neufeld HN
    Isr J Med Sci; 1966; 2(3):329-32. PubMed ID: 4380999
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia.
    Eidher U; Freihoff F; Kaltenbrunner W; Steinbach K
    Pacing Clin Electrophysiol; 2006 Apr; 29(4):358-62. PubMed ID: 16650262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with early atrial fibrillation after ablation of common atrial flutter. A single centre prospective study.
    Da Costa A; Romeyer C; Mourot S; Messier M; Cerisier A; Faure E; Isaaz K
    Eur Heart J; 2002 Mar; 23(6):498-506. PubMed ID: 11863353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between subjective symptoms and trans-telephonic ECG findings in patients with symptomatic paroxysmal atrial fibrillation and flutter.
    Atarashi H; Ogawa S; Inoue H;
    J Cardiol; 2008 Oct; 52(2):102-10. PubMed ID: 18922383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nifekalant for acute conversion of atrial flutter: the possible termination mechanism of typical atrial flutter.
    Morita N; Tanaka K; Yodogawa K; Hayashi M; Akutsu K; Yamamoto T; Satoh N; Kobayashi Y; Katoh T; Takano T
    Pacing Clin Electrophysiol; 2007 Oct; 30(10):1242-53. PubMed ID: 17897127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
    Naccarelli GV; Dorian P; Hohnloser SH; Coumel P
    Am J Cardiol; 1996 Jan; 77(3):53A-59A. PubMed ID: 8607392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia?
    Wiesfeld AC; Ansink JM; van Veldhuisen DJ; van Gelder IC
    Int J Cardiol; 2006 Feb; 107(1):140-1. PubMed ID: 15990183
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.
    Madonia S; De Simone M; Brai G; Gozzo D; Gristina A; Luciano L; Maisano S; Migliore G; Mineo R; Muzzo MP; Nicchi F; Randazzo A; Raspanti G; Rotolo G; Russo A; Sagona F; Schirosa M; Spinello M; Stancampiano R; Geraci E
    Ital Heart J; 2000 Jul; 1(7):475-9. PubMed ID: 10933330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.